Drug Interactions between Marqibo and miglustat
This report displays the potential drug interactions for the following 2 drugs:
- Marqibo (vincristine liposome)
- miglustat
Interactions between your drugs
No interactions were found between Marqibo and miglustat. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
Marqibo
A total of 436 drugs are known to interact with Marqibo.
- Marqibo is in the drug class mitotic inhibitors.
- Marqibo is used to treat Acute Lymphoblastic Leukemia.
miglustat
A total of 1 drugs are known to interact with miglustat.
- Miglustat is in the drug class miscellaneous metabolic agents.
-
Miglustat is used to treat the following conditions:
- Gaucher Disease
- Niemann-Pick Disease (off-label)
- Pompe Disease
Drug and food interactions
migLUstat food
Applies to: miglustat
Food may delay and/or reduce the absorption of miglustat (brand name Opfolda). This brand of miglustat should be administered on an empty stomach with unsweetened beverages (e.G., water, tea or coffee with no cream, sugar, or sweeteners) at least 2 hours before or 2 hours after food. Other miglustat products (brand names Zavesca and Yargesa) can be taken with or without food. MigLUstat may also cause diarrhea. Talk to your doctor if you are experiencing diarrhea or other digestive problems. Your doctor may suggest a dose adjustment, taking your medication between meals, and/or modifying your diet to have less sucrose, lactose, and other carbohydrates. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.